0 XP   0   0   0

Affymax Inc.
Buy, Hold or Sell?

Should you buy, hold or sell Affymax?

I guess you are interested in Affymax Inc.. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

Let's analyse Affymax

Let's start. I'm going to help you getting a better view of Affymax Inc.. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

  1. Company's Financial Health
    A deep dive into the books. How are the numbers doing? Is Affymax Inc. even making a profit? Is the company skyrocketing? Or is it sinking like the Titanic. The trend is your friend.
  2. Market Valuation
    Finally, you now have an insight of how Affymax Inc. is doing in the market. If the company is worth buying. The latest step is to find out how other investors value Affymax Inc.. The closing price on 2023-03-24 was $0.004 per share. Is the company over- or underpriced?
  3. Key Performance Indicators
    A total overlook on how the company is doing. Based on the (trends in) the key performance indicators.
Affymax Inc. Daily Candlestick Chart
Affymax Inc. Daily Candlestick Chart
Summary









1. Valuation of Affymax




Current price per share

$0.00

2. Growth of Affymax




Is Affymax growing?

Current yearPrevious yearGrowGrow %
How rich?-$1.4m$8.2m-$9.7m-679.9%

How much money is Affymax making?

Current yearPrevious yearGrowGrow %
Making money-$14.4m-$93.4m$78.9m?
Net Profit Margin-1,053.6%-99.0%--

How much money comes from the company's main activities?

3. Financial Health of Affymax




Comparing to competitors in the Biotechnology industry




  Industry Rankings (Biotechnology)  



Summary

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is unable to pay all its short-term debts.
Solvency Details
 Compared to previous yearCompared to industry
The company is just not able to pay all its debts by selling its assets.

1.1. Profitability of Affymax Inc..

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Affymax earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Affymax to the Biotechnology industry mean.
  • A Net Profit Margin of -1,053.6% means that $-10.54 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Affymax Inc.:

  • The MRQ is -1,053.6%. The company is making a huge loss. -2
  • The TTM is -1,053.6%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-1,053.6%TTM-1,053.6%0.0%
TTM-1,053.6%YOY-99.0%-954.6%
TTM-1,053.6%5Y-258.7%-794.9%
5Y-258.7%10Y-129.4%-129.4%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-1,053.6%-219.6%-834.0%
TTM-1,053.6%-341.4%-712.2%
YOY-99.0%-311.9%+212.9%
5Y-258.7%-558.0%+299.3%
10Y-129.4%-674.4%+545.0%
1.1.2. Return on Assets

Shows how efficient Affymax is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Affymax to the Biotechnology industry mean.
  • -193.8% Return on Assets means that Affymax generated $-1.94 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Affymax Inc.:

  • The MRQ is -193.8%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -193.8%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-193.8%TTM-193.8%0.0%
TTM-193.8%YOY-79.0%-114.8%
TTM-193.8%5Y-67.0%-126.8%
5Y-67.0%10Y-33.5%-33.5%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-193.8%-12.6%-181.2%
TTM-193.8%-12.2%-181.6%
YOY-79.0%-11.4%-67.6%
5Y-67.0%-15.2%-51.8%
10Y-33.5%-17.5%-16.0%
1.1.3. Return on Equity

Shows how efficient Affymax is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Affymax to the Biotechnology industry mean.
  • 0.0% Return on Equity means Affymax generated $0.00 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Affymax Inc.:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-1,128.0%+1,128.0%
TTM-5Y-245.6%+245.6%
5Y-245.6%10Y-122.8%-122.8%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--15.4%+15.4%
TTM--16.1%+16.1%
YOY-1,128.0%-13.3%-1,114.7%
5Y-245.6%-19.8%-225.8%
10Y-122.8%-20.7%-102.1%

1.2. Operating Efficiency of Affymax Inc..

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Affymax is operating .

  • Measures how much profit Affymax makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Affymax to the Biotechnology industry mean.
  • An Operating Margin of -2,777.0% means the company generated $-27.77  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Affymax Inc.:

  • The MRQ is -2,777.0%. The company is operating very inefficient. -2
  • The TTM is -2,777.0%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ-2,777.0%TTM-2,777.0%0.0%
TTM-2,777.0%YOY-95.4%-2,681.6%
TTM-2,777.0%5Y-602.0%-2,175.0%
5Y-602.0%10Y-301.0%-301.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-2,777.0%-228.3%-2,548.7%
TTM-2,777.0%-321.4%-2,455.6%
YOY-95.4%-350.6%+255.2%
5Y-602.0%-540.9%-61.1%
10Y-301.0%-660.9%+359.9%
1.2.2. Operating Ratio

Measures how efficient Affymax is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 37.43 means that the operating costs are $37.43 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Affymax Inc.:

  • The MRQ is 37.431. The company is inefficient in keeping operating costs low. -1
  • The TTM is 37.431. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ37.431TTM37.4310.000
TTM37.431YOY2.979+34.452
TTM37.4315Y9.573+27.858
5Y9.57310Y65.042-55.469
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ37.4313.426+34.005
TTM37.4314.100+33.331
YOY2.9794.671-1.692
5Y9.5737.250+2.323
10Y65.0428.489+56.553

1.3. Liquidity of Affymax Inc..

1.3. Liquidity
1.3.1. Current Ratio

Measures if Affymax is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 0.71 means the company has $0.71 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Affymax Inc.:

  • The MRQ is 0.713. The company is unable to pay all its short-term debts. -2
  • The TTM is 0.713. The company is unable to pay all its short-term debts. -2
Trends
Current periodCompared to+/- 
MRQ0.713TTM0.7130.000
TTM0.713YOY1.035-0.322
TTM0.7135Y1.828-1.115
5Y1.82810Y0.914+0.914
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.7134.890-4.177
TTM0.7135.355-4.642
YOY1.0356.134-5.099
5Y1.8286.368-4.540
10Y0.9146.495-5.581
1.3.2. Quick Ratio

Measures if Affymax is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Affymax to the Biotechnology industry mean.
  • A Quick Ratio of 0.00 means the company can pay off $0.00 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Affymax Inc.:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.000
TTM-YOY0.283-0.283
TTM-5Y0.754-0.754
5Y0.75410Y3.094-2.340
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-4.342-4.342
TTM-4.966-4.966
YOY0.2835.571-5.288
5Y0.7545.930-5.176
10Y3.0945.918-2.824

1.4. Solvency of Affymax Inc..

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Affymax assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Affymax to Biotechnology industry mean.
  • A Debt to Asset Ratio of 1.19 means that Affymax assets are financed with 119.2% credit (debt) and the remaining percentage (100% - 119.2%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Affymax Inc.:

  • The MRQ is 1.192. The company is just not able to pay all its debts by selling its assets. -1
  • The TTM is 1.192. The company is just not able to pay all its debts by selling its assets. -1
Trends
Current periodCompared to+/- 
MRQ1.192TTM1.1920.000
TTM1.192YOY0.930+0.262
TTM1.1925Y0.723+0.469
5Y0.72310Y0.591+0.132
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ1.1920.290+0.902
TTM1.1920.282+0.910
YOY0.9300.278+0.652
5Y0.7230.373+0.350
10Y0.5910.411+0.180
1.4.2. Debt to Equity Ratio

Measures if Affymax is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Affymax to the Biotechnology industry mean.
  • A Debt to Equity ratio of 0.0% means that company has $0.00 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Affymax Inc.:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.000
TTM-YOY13.276-13.276
TTM-5Y3.363-3.363
5Y3.36310Y3.751-0.388
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-0.333-0.333
TTM-0.341-0.341
YOY13.2760.274+13.002
5Y3.3630.418+2.945
10Y3.7510.453+3.298

2. Market Valuation of Affymax Inc.

2. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Affymax generates.

  • Above 15 is considered overpriced but always compare Affymax to the Biotechnology industry mean.
  • A PE ratio of -2.03 means the investor is paying $-2.03 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Affymax Inc.:

  • The EOD is -0.010. Company is losing money. -2
  • The MRQ is -2.027. Company is losing money. -2
  • The TTM is -2.027. Company is losing money. -2
Trends
Current periodCompared to+/- 
EOD-0.010MRQ-2.027+2.017
MRQ-2.027TTM-2.0270.000
TTM-2.027YOY-7.621+5.594
TTM-2.0275Y-6.280+4.253
5Y-6.28010Y-3.140-3.140
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-0.010-5.986+5.976
MRQ-2.027-7.721+5.694
TTM-2.027-10.277+8.250
YOY-7.621-21.989+14.368
5Y-6.280-17.927+11.647
10Y-3.140-18.153+15.013
2.2. Price Earnings to Growth Ratio

Measures the predicted future growth of Affymax.

  • Lower is better.
  • A PEG ratio of 1 means the market price of the stock and the expected future earnings are on par.

Let's take a look of the Price Earnings to Growth Ratio trends of Affymax Inc.:

  • The MRQ is -1.098. Very Bad. -2
  • The TTM is -1.098. Very Bad. -2
Trends
Current periodCompared to+/- 
MRQ-1.098TTM-1.0980.000
TTM-1.098YOY-15.951+14.852
TTM-1.0985Y-5.113+4.014
5Y-5.11310Y-5.1130.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-1.098-5.636+4.538
TTM-1.098-7.915+6.817
YOY-15.951-15.813-0.138
5Y-5.113-13.782+8.669
10Y-5.113-13.070+7.957

2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Affymax is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of -20.48 means the investor is paying $-20.48 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Affymax Inc.:

  • The EOD is -0.105. Bad. Book ratio is negative. -2
  • The MRQ is -20.478. Bad. Book ratio is negative. -2
  • The TTM is -20.478. Bad. Book ratio is negative. -2
Trends
Current periodCompared to+/- 
EOD-0.105MRQ-20.478+20.373
MRQ-20.478TTM-20.4780.000
TTM-20.478YOY85.972-106.450
TTM-20.4785Y17.211-37.689
5Y17.21110Y14.862+2.349
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-0.1051.733-1.838
MRQ-20.4782.046-22.524
TTM-20.4782.608-23.086
YOY85.9724.052+81.920
5Y17.2113.689+13.522
10Y14.8623.871+10.991
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Affymax Inc. compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.259-0.2590%-1.806+597%-0.056-79%-0.004-99%
Book Value Growth---0.172-0.1720%0.109-258%1.903-109%1.628-111%
Book Value Per Share---0.038-0.0380%0.221-117%1.186-103%1.368-103%
Book Value Per Share Growth---0.172-0.1720%0.109-258%1.903-109%1.628-111%
Current Ratio--0.7130.7130%1.035-31%1.828-61%0.914-22%
Debt To Asset Ratio--1.1921.1920%0.930+28%0.723+65%0.591+102%
Debt To Equity Ratio----0%13.276-100%3.363-100%3.751-100%
Dividend Per Share----0%-0%-0%-0%
Eps---0.385-0.3850%-2.492+548%-0.978+154%-0.489+27%
Eps Growth--1.8461.8460%0.478+286%-0.012+101%-0.012+101%
Free Cash Flow Per Share---1.796-1.7960%-1.033-42%-1.529-15%-0.867-52%
Free Cash Flow Per Share Growth--0.2620.2620%1.471-82%0.756-65%0.756-65%
Free Cash Flow To Equity Per Share---2.056-2.0560%-0.417-80%-1.081-47%0.067-3184%
Free Cash Flow To Equity Per Share Growth---2.930-2.9300%1.152-354%-0.047-98%-0.047-98%
Gross Profit Margin--1.0001.0000%1.0000%0.800+25%0.400+150%
Intrinsic Value_10Y_max---291.761--------
Intrinsic Value_10Y_min---241.099--------
Intrinsic Value_1Y_max---7.729--------
Intrinsic Value_1Y_min---7.511--------
Intrinsic Value_3Y_max---39.615--------
Intrinsic Value_3Y_min---37.120--------
Intrinsic Value_5Y_max---91.261--------
Intrinsic Value_5Y_min---82.454--------
Net Profit Margin---10.536-10.5360%-0.990-91%-2.587-75%-1.294-88%
Operating Margin---27.770-27.7700%-0.954-97%-6.020-78%-3.010-89%
Operating Ratio--37.43137.4310%2.979+1157%9.573+291%65.042-42%
Pb Ratio-0.105+99%-20.478-20.4780%85.972-124%17.211-219%14.862-238%
Pe Ratio-0.010+99%-2.027-2.0270%-7.621+276%-6.280+210%-3.140+55%
Peg Ratio---1.098-1.0980%-15.951+1352%-5.113+365%-5.113+365%
Price Per Share0.004-19400%0.7800.7800%18.990-96%11.554-93%12.416-94%
Price To Total Gains Ratio-0.015+99%-3.012-3.0120%-10.514+249%23.701-113%13.568-122%
Profit Growth--1.8461.8460%0.478+286%-0.012+101%-0.012+101%
Quick Ratio----0%0.283-100%0.754-100%3.094-100%
Return On Assets---1.938-1.9380%-0.790-59%-0.670-65%-0.335-83%
Return On Equity----0%-11.2800%-2.4560%-1.2280%
Revenue Growth--0.0150.0150%1.978-99%0.956-98%18.820-100%
Total Gains Per Share---0.259-0.2590%-1.806+597%-0.056-79%-0.004-99%
Total Gains Per Share Growth--1.8571.8570%-19.628+1157%-2.858+254%-1.319+171%
Usd Book Value---1428000.000-1428000.0000%8281000.000-117%44460400.000-103%51269700.000-103%
Usd Book Value Change Per Share---0.259-0.2590%-1.806+597%-0.056-79%-0.004-99%
Usd Book Value Per Share---0.038-0.0380%0.221-117%1.186-103%1.368-103%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps---0.385-0.3850%-2.492+548%-0.978+154%-0.489+27%
Usd Free Cash Flow----0%-0%-0%-0%
Usd Free Cash Flow Per Share---1.796-1.7960%-1.033-42%-1.529-15%-0.867-52%
Usd Free Cash Flow To Equity Per Share---2.056-2.0560%-0.417-80%-1.081-47%0.067-3184%
Usd Price Per Share0.004-19400%0.7800.7800%18.990-96%11.554-93%12.416-94%
Usd Profit---14424000.000-14424000.0000%-93412000.000+548%-36655600.000+154%-18327800.000+27%
Usd Revenue--1369000.0001369000.0000%94370000.000-99%74175800.000-98%51001700.000-97%
Usd Total Gains Per Share---0.259-0.2590%-1.806+597%-0.056-79%-0.004-99%
 EOD+2 -3MRQTTM+0 -0YOY+14 -235Y+10 -2810Y+11 -27

3.2. Fundamental Score

Let's check the fundamental score of Affymax Inc. based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-0.010
Price to Book Ratio (EOD)Between0-1-0.105
Net Profit Margin (MRQ)Greater than0-10.536
Operating Margin (MRQ)Greater than0-27.770
Quick Ratio (MRQ)Greater than10.000
Current Ratio (MRQ)Greater than10.713
Debt to Asset Ratio (MRQ)Less than11.192
Debt to Equity Ratio (MRQ)Less than10.000
Return on Equity (MRQ)Greater than0.150.000
Return on Assets (MRQ)Greater than0.05-1.938
Total1/10 (10.0%)

3.3. Technical Score

Let's check the technical score of Affymax Inc. based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5043.177
Ma 20Greater thanMa 500.006
Ma 50Greater thanMa 1000.008
Ma 100Greater thanMa 2000.007
OpenGreater thanClose0.004
Total2/5 (40.0%)



Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2009-12-312010-12-312011-12-312012-12-312013-12-31
Total Stockholder Equity 66,9055,64272,5473,45075,997-67,7168,281-9,709-1,428



Latest Balance Sheet

Balance Sheet of 2013-12-31. Currency in USD. All numbers in thousands.

Summary
Total Assets7,443
Total Liabilities8,871
Total Stockholder Equity-1,428
 As reported
Total Liabilities 8,871
Total Stockholder Equity+ -1,428
Total Assets = 7,443

Assets

Total Assets7,443
Total Current Assets6,322
Long-term Assets6,322
Total Current Assets
Cash And Cash Equivalents 5,597
Other Current Assets 725
Total Current Assets  (as reported)6,322
Total Current Assets  (calculated)6,322
+/-0
Long-term Assets
Long-term Assets  (as reported)0
Long-term Assets  (calculated)0
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities8,871
Long-term Liabilities-
Total Stockholder Equity-1,428
Total Current Liabilities
Accounts payable 101
Other Current Liabilities 8,504
Total Current Liabilities  (as reported)8,871
Total Current Liabilities  (calculated)8,605
+/- 266
Long-term Liabilities
Long-term Liabilities  (as reported)0
Long-term Liabilities  (calculated)0
+/-0
Total Stockholder Equity
Common Stock37
Total Stockholder Equity (as reported)-1,428
Total Stockholder Equity (calculated)37
+/- 1,465
Other
Net Tangible Assets -1,428



Balance Sheet

Currency in USD. All numbers in thousands.

 Trend2013-12-312012-12-312011-12-312010-12-312009-12-312008-12-312007-12-312006-12-312005-12-312004-12-31
> Total Assets 
27,728
60,960
249,988
225,792
167,720
211,510
131,387
118,995
118,217
7,443
7,443118,217118,995131,387211,510167,720225,792249,98860,96027,728
   > Total Current Assets 
0
0
0
0
0
0
99,542
107,620
102,510
6,322
6,322102,510107,62099,542000000
       Cash And Cash Equivalents 
1,657
14,399
147,541
108,215
24,046
125,296
63,499
54,339
68,265
5,597
5,59768,26554,33963,499125,29624,046108,215147,54114,3991,657
       Short-term Investments 
23,063
43,494
77,802
60,133
70,684
35,303
33,582
44,165
9,717
0
09,71744,16533,58235,30370,68460,13377,80243,49423,063
       Net Receivables 
0
0
0
0
0
0
0
6,937
18,365
0
018,3656,9370000000
   > Long-term Assets 0000000000
       Property Plant Equipment 
1,053
1,110
2,014
4,470
6,952
5,469
3,982
3,013
2,981
0
02,9813,0133,9825,4696,9524,4702,0141,1101,053
       Long Term Investments 
0
0
0
0
0
0
19,876
0
2,323
0
02,323019,876000000
> Total Liabilities 
2,494
5,867
133,089
141,607
158,736
144,605
58,840
42,998
109,936
8,871
8,871109,93642,99858,840144,605158,736141,607133,0895,8672,494
   > Total Current Liabilities 
2,146
5,377
11,972
55,698
93,351
133,721
47,617
20,303
99,075
8,871
8,87199,07520,30347,617133,72193,35155,69811,9725,3772,146
       Short-term Debt 
0
0
0
0
0
0
0
0
8,844
0
08,84400000000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
8,844
0
08,84400000000
       Accounts payable 
806
3,336
9,113
9,348
614
464
321
941
6,591
101
1016,5919413214646149,3489,1133,336806
       Other Current Liabilities 
1,340
1,818
2,566
45,478
92,567
124,065
24,455
3,998
62,873
8,504
8,50462,8733,99824,455124,06592,56745,4782,5661,8181,340
   > Long-term Liabilities 0000000000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
5,174
0
0
005,1740000000
> Total Stockholder Equity
25,234
55,093
116,899
84,185
8,984
66,905
72,547
75,997
8,281
-1,428
-1,4288,28175,99772,54766,9058,98484,185116,89955,09325,234
   Common Stock
0
0
15
15
15
24
25
36
37
37
373736252415151500
   Retained Earnings Total Equity0000000000
   Accumulated Other Comprehensive Income 0000000000
   Capital Surplus 0000000000
   Treasury Stock0000000000
   Other Stockholders Equity 
0
0
0
0
0
0
31
18
-2
0
0-21831000000



Balance Sheet

Currency in USD. All numbers in thousands.




Cash Flow

Currency in USD. All numbers in thousands.




Income Statement

Currency in USD. All numbers in thousands.


Latest Income Statement (annual, 2013-12-31)

Gross Profit (+$)
totalRevenue1,369
Cost of Revenue-11,857
Gross Profit-10,488-10,488
 
Operating Income (+$)
Gross Profit-10,488
Operating Expense-39,386
Operating Income-38,017-49,874
 
Operating Expense (+$)
Research Development11,857
Selling General Administrative27,529
Selling And Marketing Expenses-
Operating Expense39,38639,386
 
Net Interest Income (+$)
Interest Income-
Interest Expense-0
Net Interest Income-0
 
Pretax Income (+$)
Operating Income-38,017
Net Interest Income-
Other Non-Operating Income Expenses-
Income Before Tax (EBT)-16,582-59,452
EBIT - interestExpense = -38,017
-16,582
-14,424
Interest Expense0
Earnings Before Interest and Taxes (ebit)-38,017-16,582
Earnings Before Interest and Taxes (ebitda)-
 
After tax Income (+$)
Income Before Tax-16,582
Tax Provision--
Net Income From Continuing Ops-14,424-16,582
Net Income-14,424
Net Income Applicable To Common Shares-14,424
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring20,480
Other Operating Expenses-
Total Other Income/Expenses Net21,4350
 

Comments

Join the conversation.

Leave a comment

Stay informed with my latest content.

Subscribe to my newsletter and receive an email as soon as I add content to PenkeTrading.com.


By clicking Register, you agree to the General Terms and Conditions.
Penke's Market Notifications
AHZ0.F
19 hours ago

I found you a STOCH Bearish Hidden Divergence on the daily chart of AHZ0.F.

AHZ0.F Daily Candlestick Chart
9VU.F
19 hours ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of 9VU.F.

9VU.F Daily Candlestick Chart
9TD.F
19 hours ago

I found you a STOCH Bearish Hidden Divergence on the daily chart of 9TD.F.

9TD.F Daily Candlestick Chart
9PZ.F
19 hours ago

I found you a Golden Cross on the daily chart of 9PZ.F.

9PZ.F Daily Candlestick Chart
98B.F
19 hours ago

I found you a STOCH Bearish Hidden Divergence on the daily chart of 98B.F.

98B.F Daily Candlestick Chart
8ZU.F
19 hours ago

I found you a STOCH Bullish Reversal Divergence on the daily chart of 8ZU.F.

8ZU.F Daily Candlestick Chart
8QQ.F
19 hours ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of 8QQ.F.

8QQ.F Daily Candlestick Chart
8K6.F
19 hours ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of 8K6.F.

8K6.F Daily Candlestick Chart
8J4.F
19 hours ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of 8J4.F.

8J4.F Daily Candlestick Chart
8HQ.F
19 hours ago

I found you a RSI Bullish Reversal Divergence on the daily chart of 8HQ.F.

8HQ.F Daily Candlestick Chart
7ZG.F
19 hours ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of 7ZG.F.

7ZG.F Daily Candlestick Chart
7O41.F
19 hours ago

I found you a STOCH Bearish Hidden Divergence on the daily chart of 7O41.F.

7O41.F Daily Candlestick Chart
7N20.F
19 hours ago

I found you a STOCH Bearish Hidden Divergence on the daily chart of 7N20.F.

7N20.F Daily Candlestick Chart
7IA.F
19 hours ago

I found you a MACD Bearish Reversal Divergence on the daily chart of 7IA.F.

7IA.F Daily Candlestick Chart
7F4.F
19 hours ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of 7F4.F.

7F4.F Daily Candlestick Chart
77Q.F
19 hours ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of 77Q.F.

77Q.F Daily Candlestick Chart
74G.F
19 hours ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of 74G.F.

74G.F Daily Candlestick Chart
6YG.F
19 hours ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of 6YG.F.

6YG.F Daily Candlestick Chart
6WZ.F
19 hours ago

I found you a RSI Bearish Hidden Divergence on the daily chart of 6WZ.F.

6WZ.F Daily Candlestick Chart
6VY.F
19 hours ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of 6VY.F.

6VY.F Daily Candlestick Chart
6UY.F
19 hours ago

I found you a Death Cross on the daily chart of 6UY.F.

6UY.F Daily Candlestick Chart
6R4.F
19 hours ago

I found you a STOCH Bearish Hidden Divergence on the daily chart of 6R4.F.

6R4.F Daily Candlestick Chart
6NCA.F
19 hours ago

I found you a STOCH Bearish Hidden Divergence on the daily chart of 6NCA.F.

6NCA.F Daily Candlestick Chart
65R.F
19 hours ago

I found you a Death Cross on the daily chart of 65R.F.

65R.F Daily Candlestick Chart